Boothbay Fund Management, LLC Sangamo Therapeutics, Inc Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$6.21 - $11.83 $68,931 - $131,313	-11,100 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $56,055 - $98,235	11,100 New	11,100 $71,000
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $334,080 - $487,680	-25,600 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $355,840 - $506,880	25,600 New	25,600 $364,000

133

86.3M

35.9K

156K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $133M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.